I am bitterly disappointed with the result. There is no point...

I am bitterly disappointed with the result. There is no point selling now. We can just hope that given Folfiri on other trials yielded around 4.9 months, maybe there is that hope that a smaller percentage on HA-I have a longer PFS. Maybe (wishful thinking) FDA might allow that trial result. Best to wait the analysis then decide how you want to proceed with your shares. So roughly 2-3 months for that report???

Boy, HHL got it all wrong also. This is the last I will venture into biotechs.